Skip to main content
×
Home

Changing epidemiology of methicillin-resistant Staphylococcus aureus in Alberta, Canada: population-based surveillance, 2005–2008

  • J. KIM (a1), C. FERRATO (a2), G. R. GOLDING (a3), M. R. MULVEY (a3), K. A. SIMMONDS (a4), L. W. SVENSON (a4) (a5), G. KEAYS (a5), L. CHUI (a2) (a6), M. LOVGREN (a2) and M. LOUIE (a1) (a2) (a7) (a8)...
Summary
SUMMARY

Increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) has been reported in Canada. We report the results of a prospective surveillance of MRSA infections in Alberta over a consecutive 3-year period. A total of 8910 unique clinical MRSA isolates was analysed from July 2005 to June 2008. The incidence of MRSA infection increased over the study period and was highest in males, age group ⩾85 years, and the Calgary Area. CMRSA10 (USA300) and CMRSA2 (USA100/800) were the most common PFGE strain types, representing 53·0% and 27·9% of all isolates, respectively. Significant differences were noted between MRSA strains in the source of infection and antimicrobial susceptibility. The incidence of MRSA infection in Alberta has nearly doubled in the last 3 years; this is attributed to the emergence of CMRSA10 as the predominant strain.

Copyright
Corresponding author
*Author for correspondence: M. Louie, M.D., FRCPC, 3030 Hospital Drive NW, Calgary, Alberta, Canada, T2N 4W4. (Email: marie.louie@albertahealthservices.ca)
References
Hide All
1.Stefani S, Varaldo PE. Epidemiology of methicillin-resistant staphylococci in Europe. Clinical Microbiology and Infection 2003; 9: 11791186.
2.Jarvis WR, et al. National prevalence of methicillin-resistant Staphylococcus aureus inpatients at US health care facilities, 2006. American Journal of Infection Control 2007; 35: 631637.
3.European Antimicrobial Resistance Surveillance System. Annual report 2008 (http://www.rivm.nl/earss/result/Monitoring_reports/). Accessed 10 June 2010.
4.Hiramatsu K, et al. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends in Microbiology 2001; 9: 486493.
5.Mulvey MR, et al. Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. Journal of Clinical Microbiology 2001; 39: 34813485.
6.Tenover FC, et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. Journal of Clinical Microbiology 2006; 44: 108118.
7.Simor AE, et al. Characterization and proposed nomenclature of epidemic strains of MRSA in Canada. Canadian Journal of Infectious Diseases 1999; 10: 333336.
8.Christianson S, et al. Comparative genomics of Canadian epidemic lineages of methicillin-resistant Staphylococcus aureus. Journal of Clinical Microbiology 2007; 45: 19041911.
9.Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus – Minnesota and North Dakota, 1997–1999. Journal of the American Medical Association 1999; 282: 11231125.
10.Herold BC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. Journal of the American Medical Association 1998; 279: 593598.
11.Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clinical Infectious Diseases 2008; 46: S344–349.
12.Moran GJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. New England Journal of Medicine 2006; 355: 666.
13.King MD, et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Annals Internal Medicine 2006; 144: 309317.
14.Klevens RM, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Journal of the American Medical Association 2007; 298: 17631771.
15.Simor AE, et al. Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: national surveillance and changing epidemiology, 1995–2007. Infection Control and Hospital Epidemiology 2010; 31: 348356.
16.Gilbert M, et al. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. Canadian Medical Association Journal 2006; 175: 149154.
17.Tenover FC, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of Clinical Microbiology 1995; 33: 22332239.
18.Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 17th informational supplement. CLSI document MS 100-S17. Wayne, PA: CLSI; 2007.
19.Walker ES, et al. A decline in mupirocin resistance in methicillin-resistant Staphylococcus aureus accompanied administrative control of prescriptions. Journal of Clinical Microbiology 2004; 42: 27922795.
20.Skov R, Frimodt-Møller N, Espersen F. Correlation of MIC methods and tentative interpretive criteria for disk diffusion susceptibility testing using NCCLS methodology for fusidic acid. Diagnostic Microbiology and Infectious Disease 2001; 40: 111116.
21.Zar JH. Biostatistical Analysis, 4th edn. New Jersey: Prentice Hall, 1999.
22.Cimolai N. Methicillin-resistant Staphylococcus aureus in Canada: a historical perspective and lessons learned. Canadian Journal of Microbiology 2010; 56: 89–120.
23.Fridkin SK, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. New England Journal of Medicine 2005; 352: 14361444.
24.Liu C, et al. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004–2005. Clinical Infectious Diseases 2008; 46: 16371646.
25.Huang H, et al. Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California. Journal of Clinical Microbiology 2006; 44: 24232427.
26.Patel M, et al. Emergence of USA300 MRSA in a tertiary medical centre: implications for epidemiological studies. Journal of Hospital Infection 2008; 68: 208213.
27.Naimi TS, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. Journal of the American Medical Association 2003; 290: 29762984.
28.Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Annals of Internal Medicine 1982; 97: 309317.
29.Monnet DL. Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control. Infection Control and Hospital Epidemiology 1998; 19: 552559.
30.Simmonds KA, et al. Epidemiology of community associated methicillin-resistant Staphylococcus aureus. Canada Communicable Disease Report 2008; 34: 19.
31.Simor AE, et al. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrobial Agents and Chemotherapy 2007; 51: 38803886.
32.Deurenberg RH, Stobberingh EE. The Evolution of Staphylococcus aureus. Infection, Genetics and Evolution 2008; 8: 747763.
33.DeLeo FR, Chambers HF. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomic era. Journal of Clinical Investigation 2009; 119: 24642474.
34.Hawkes M, et al. Community-associated MRSA: superbug at our doorstep. Canadian Medical Association Journal 2007; 176: 5456.
35.Klevens M, et al. Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerging Infectious Diseases 2006; 12: 19911993.
36.Allen UD. Public health implications of MRSA in Canada. Canadian Medical Association Journal 2006; 175: 161.
37.Patel M, et al. Dissemination of community-associated methicillin-resistant Staphylococcus aureus in a tertiary care hospital. Southern Medical Journal 2008; 101: 4045.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 1
Total number of PDF views: 6 *
Loading metrics...

Abstract views

Total abstract views: 95 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 23rd November 2017. This data will be updated every 24 hours.